Corbevax, Covovax and Molnupiravir approved for restricted use in emergency situation
CDSCO has received total of 22 applications for manufacturing and marketing of the drug Molnupiravir in the country
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Serum Institute of India & Novavax receive EUA in India for Covovax
Novavax/SII vaccine recently received Emergency Use Listing (EUL) with the World Health Organization (WHO), EUA in Indonesia and…
NITI Aayog releases fourth edition of state health index
Maximum annual incremental performance shown by UP, Assam and Telangana among ‘Larger States’; Mizoram & Meghalaya among…
Better vascular access management for infection control
As vascular access devices are one of the major sources of infections in a hospital setting,
Dr Prashant Borade, Head Critical…
India to give COVID-19 booster shots to healthcare workers from Jan 10
In a national address, PM also said those aged 15-18 would start receiving COVID-19 vaccinations from Jan 3 and those above 60…
- Advertisement -
RaphaCure partners with Zeebon for foraying into North East market
The entry of RaphaCure is expected to bring in a paradigm shift in how healthcare is delivered in North-Eastern states that are…
Zorgers raises angel round for further expansion
The funds will be used towards expanding their presence across geographies and for mobilising 50,000 healthcare professionals in…
Rosatom Healthcare conducts webinar on how innovations in nuclear medicines is revolutionising…
Rusatom Healthcare is going to co-operate with local companies for delivery high technology solutions in medicine which will…
Covaxin receives approval for emergency use in 12-18 years old children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Roche COVID-19 at-home test granted FDA Emergency Use Authorisation
Starting in January, the COVID-19 at-home test will be available across the United States and in accordance with local guidelines…